Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) saw a significant growth in short interest in August. As of August 14th, there was short interest totaling 28,130 shares, a growth of 69.4% from the July 30th total of 16,610 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 35,044 shares, the short-interest ratio is presently 0.8 days.
Lonza Group Trading Down 0.6%
Shares of OTCMKTS:LZAGY opened at $70.83 on Wednesday. The business has a fifty day simple moving average of $70.19 and a 200-day simple moving average of $65.96. The company has a quick ratio of 1.77, a current ratio of 2.24 and a debt-to-equity ratio of 0.42. Lonza Group has a 52 week low of $58.53 and a 52 week high of $74.36.
Lonza Group Company Profile
Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.
The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.
Featured Articles
- Five stocks we like better than Lonza Group
- What Does Apple’s TV Price Hike Say About Where the Stock Is Heading?
- Will the Most Successful Quantum Firms Be Software Companies?
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
